Our Clinical Trials
The study is examining if lowering Lipoprotein (a), a type of cholesterol, can reduce the risk of cardiovascular events. If you have known cardiovascular disease or are at risk of cardiovascular disease (including a family history), you might be eligible for this 4-year study. See below for more details.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.
Apply NowThis 14-week clinical trial aims to assess the safety and effectiveness of a potential new oral treatment in adults aged 18–65 who experience panic attacks but are not currently taking benzodiazepines or affected by other major psychiatric disorders.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.
Apply NowA 51-week, placebo-controlled study evaluating the effectiveness of different dosages of a new investigational weight loss injectable treatment.
This study is being conducted at our Western Sydney, Central Coast, and Brisbane sites.
Apply Now